StockWatch
·
Pharmaceuticals
Corporate Action17 Nov 2026, 04:41 pm

Godavari Drugs: Aksheit Kakani Converts Warrants to Shares

AI Summary

Godavari Drugs Limited has filed a disclosure regarding Aksheit Kakani, a Promoter, converting 50,000 convertible warrants into 50,000 equity shares. Following this conversion, Aksheit Kakani's shareholding in the company has changed. Before the transaction, the holding was 3.45% of total capital and 3.01% of diluted capital. After the conversion, the holding is 3.64% of total capital and 3.41% of diluted capital. The transaction involved the allotment of 50,000 equity shares upon conversion of warrants on November 17, 2026.

Key Highlights

  • Promoter Aksheit Kakani converted 50,000 warrants to equity shares.
  • Holding increased from 3.45% to 3.64% of total capital.
  • Diluted holding increased from 3.01% to 3.41%.
  • Transaction type was allotment upon conversion of warrants.
  • Effective date of conversion was November 17, 2026.